Serum resistin and glomerular filtration rate in patients with type 2 diabetes

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Moreno, Lorena Ortega ^a   Salvemini, Lucia ^a   Mendonca, Christine ^b   Copetti, Massimiliano ^a   De Bonis, Concetta ^a   De Cosmo, Salvatore ^a   Doria, Alessandro ^b,c   Trischitta, Vincenzo ^a,d   Menzaghi, Claudia ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b JOSLIN DIABETES CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; HEMOGLOBIN A1C; RESISTIN;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN TREATMENT; ITALY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SMOKING; UNITED STATES; WAIST CIRCUMFERENCE; AGED; BLOOD; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; ODDS RATIO; URINE;

AGED; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RESISTIN;

EID: 84926451217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119529     Document Type: Article

References (37)

1. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005; 365: 331-340. PMID: 15664230
2. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011; 80: 17-28. doi: 10.1038/ki.2010.483 PMID: 21150873
3. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011; 79: 1341-1352. doi: 10.1038/ki.2010.536 PMID: 21307840
4. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004; 140: 167-174. PMID: 14757614
5. De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant. 2013; 28: 29-36. doi: 10.1093/ndt/gfs290 PMID: 23048172
6. Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011; 7: 327-340. doi: 10.1038/nrneph.2011.51 PMID: 21537349
7. Kronenberg F. Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol. 2009; 5: 677-689. doi: 10.1038/nrneph.2009.173 PMID: 19935815
8. Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes. 2006; 55: 1537-1545. PMID: 16731815
9. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001; 409: 307-312. PMID: 11201732
10. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003; 300: 472-476. PMID: 12504108
11. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004; 27: 2450-2457. PMID: 15451915
12. Osawa H, Doi Y, Makino H, Ninomiya T, Yonemoto K, Kawamura R, et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol. 2009; 8: 60. doi: 10.1186/1475-2840-8-60 PMID: 19922611
13. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005; 111: 932-939. PMID: 15710760
14. Dimitriadis K, Tsioufis C, Selima M, Tsiachris D, Miliou A, Kasiakogias A, et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens. 2009; 23: 668-673. doi: 10.1038/jhh.2009.12 PMID: 19262583
15. Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley TH, et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension. 2007; 50: 708-714. PMID: 17785630
16. Kawamura R, Doi Y, Osawa H, Ninomiya T, Hata J, Yonemoto K, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant. 2010; 25: 3236-3240. doi: 10.1093/ndt/gfq155 PMID: 20339098
17. Menzaghi C, Salvemini L, Fini G, Thompson R, Mangiacotti D, Di Paola R, et al. Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals. PLoS One. 2012; 7: e38414. doi: 10.1371/journal.pone.0038414 PMID: 22701635
18. De Cosmo S, Copetti M, Lamacchia O, Fontana A, Massa M, Morini E, et al. Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes. Diabetes Care. 2013; 36: 2830-2835. doi: 10.2337/dc12-1906 PMID: 23637348
19. Menzaghi C, Bacci S, Salvemini L, Mendonca C, Palladino G, Fontana A, et al. Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. PLoS One. 2013; 8: e64729. doi: 10.1371/journal.pone.0064729 PMID: 23755138
20. Doria A, Wojcik J, Xu R, Gervino EV, Hauser TH, Johnstone MT, et al. Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes. Jama. 2008; 300: 2389-2397. doi: 10.1001/jama.2008.649 PMID: 19033589
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470. PMID: 10075613
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612. PMID: 19414839
23. Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A, et al. Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab. 2006; 91: 2792-2795. PMID: 16670163
24. Olkin I, Sampson A. Comparison of meta-analysis versus analysis of variance of individual patient data. Biometrics. 1998; 54: 317-322. PMID: 9544524
25. Kollerits B, Fliser D, Heid IM, Ritz E, Kronenberg F, Group MS. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int. 2007; 71: 1279-1286. PMID: 17457380
26. Menzaghi C, Xu M, Salvemini L, De Bonis C, Palladino G, Huang T, et al. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism. Cardiovasc Diabetol. 2014;13: 130 "In press".
27. Hsu WY, Chao YW, Tsai YL, Lien CC, Chang CF, Deng MC, et al. Resistin induces monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1 expression in endothelial cells via p38MAPK-dependent pathway. J Cell Physiol. 2011; 226: 2181-2188. doi: 10.1002/jcp.22555 PMID: 21520070
28. Qiu W, Chen N, Zhang Q, Zhuo L, Wang X, Wang D, et al. Resistin increases platelet P-selectin levels via p38 MAPK signal pathway. Diab Vasc Dis Res. 2014; 11: 121-124. doi: 10.1177/1479164113513912 PMID: 24396117
29. Calabrò P, Cirillo P, Limongelli G, Maddaloni V, Riegler L, Palmieri R, et al. Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-κB-dependent pathway. J Vasc Res. 2011; 48: 59-66. doi: 10.1159/000318775 PMID: 20628259
30. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovas Res. 2006; 69: 76-85. PMID: 16271710
31. von Eynatten M, Schneider JG, Hadziselimovic S, Hamann A, Bierhaus A, Nawroth PP, et al. Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes. Diabetes Care. 2005; 28: 754-755. PMID: 15735224
32. Melone M, Wilsie L, Palyha O, Strack A, Rashid S. Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9. J Am Coll Cardiol. 2012; 59: 1697-1705. doi: 10.1016/j.jacc.2011.11.064 PMID: 22554600
33. Yamauchi J, Osawa H, Takasuka T, Ochi M, Murakami A, Nishida W, et al. Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism. 2008; 57: 149-156. doi: 10.1016/j.metabol.2007.08.018 PMID: 18191042
34. Kaplan RC, Ho GY, Xue X, Rajpathak S, Cushman M, Rohan TE, et al. Within-individual stability of obesity-related biomarkers among women. Cancer Epidemiol Prev. 2007; 16: 1291-1293. PMID: 17548700
35. Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Prev. 2007; 16: 2464-2470. PMID: 18006938
36. Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, Franke AA, et al. Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Prev. 2010; 19: 938-946. doi: 10.1158/1055-9965.EPI-09-1318 PMID: 20332276
37. Menzaghi C, Trischitta V. Genetics of serum resistin: a paradigm of population-specific regulation? Diabetologia. 2010; 53: 226-228. doi: 10.1007/s00125-009-1589-z PMID: 19882136